# EDGAR Filing Document

**Accession Number:** 0001135951
**File Stem:** 0001575872-25-000504
**Filing Date:** 2025-7
**Character Count:** 14533
**Document Hash:** f84c23da898f465f26e394e28c4640bd
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001575872-25-000504.hdr.sgml**: 20250725

**ACCESSION NUMBER**: 0001575872-25-000504

**CONFORMED SUBMISSION TYPE**: 6-K

**PUBLIC DOCUMENT COUNT**: 25

**CONFORMED PERIOD OF REPORT**: 20250724

**FILED AS OF DATE**: 20250725

**DATE AS OF CHANGE**: 20250725

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** DR REDDYS LABORATORIES LTD
- **CENTRAL INDEX KEY:** 0001135951
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 000000000
- **FISCAL YEAR END:** 0331

**FILING VALUES:**
- **FORM TYPE:** 6-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-15182
- **FILM NUMBER:** 251148506

**BUSINESS ADDRESS:**
- **ADDRESS IS A NON US LOCATION:** YES
- **STREET 1:** 8-2-337, ROAD NO.3 BANJARA HILLS
- **CITY:** HYDERABAD
- **PROVINCE COUNTRY:** K7
- **ZIP:** 500-034
- **BUSINESS PHONE:** 91 40 49002900

**MAIL ADDRESS:**
- **ADDRESS IS A NON US LOCATION:** YES
- **STREET 1:** 8-2-337, ROAD NO.3 BANJARA HILLS
- **CITY:** HYDERABAD
- **PROVINCE COUNTRY:** K7
- **ZIP:** 500-034

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

Form 6-K

**REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13A-16 OR 15D-16** 

**UNDER THE SECURITIES EXCHANGE ACT OF 1934**

**July, 2025**

**Commission File Number 1-15182**

**DR. REDDY'S LABORATORIES LIMITED**

(Translation of registrant's name into English)

**8-2-337, Road No. 3, Banjara Hills**

**Hyderabad, Telangana 500 034, India**

**+91-40-49002900**

(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F ⌧&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Form 40-F ◻

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ______

**Note:** Regulation S-T Rule 101(b)(1) only permits the submission in paper of a Form 6-K if submitted solely to provide an attached annual report to security holders.

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ______

**Note:** Regulation S-T Rule 101(b)(7) only permits the submission in paper of a Form 6-K if submitted to furnish a report or other document that the registrant foreign private issuer must furnish and make public under the laws of the jurisdiction in which the registrant is incorporated, domiciled or legally organized (the registrant's "home country"), or under the rules of the home country exchange on which the registrant's securities are traded, as long as the report or other document is not a press release, is not required to be and has not been distributed to the registrant's security holders, and, if discussing a material event, has already been the subject of a Form 6-K submission or other Commission filing on EDGAR.

Indicate by check mark whether by furnishing the information contained in this Form, the registrant is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.

Yes ◻&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; No ⌧

If "Yes" is marked, indicate below the file number assigned to registrant in connection with Rule 12g3-2(b): 82-________.

**EXHIBITS** 

---

| | |
|:---|:---|
| **Exhibit<br>Number** | <br>**Description of Exhibits** |
| [99.1](rdy0785_ex99-1.htm) | [Intimation dated July 24, 2025](rdy0785_ex99-1.htm) |

---

**SIGNATURES** 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

---

| | | | |
|:---|:---|:---|:---|
|  | DR. REDDY'S LABORATORIES LIMITED <br>(Registrant) | DR. REDDY'S LABORATORIES LIMITED <br>(Registrant) | DR. REDDY'S LABORATORIES LIMITED <br>(Registrant) |
| Date: July 24, 2025  | By: | /s/ K Randhir Singh | /s/ K Randhir Singh |
|  |  | Name: | K Randhir Singh |
|  |  | Title: | Company Secretary  |

---

## Exhibit 99.1

**Exhibit 99.1**

---

| | |
|:---|:---|
| ![](rdy0785_ex99-1img01.jpg)<br>| **Dr. Reddy's Laboratories Ltd.**<br>8-2-337, Road No. 3, Banjara Hills<br>Hyderabad – 500 034, Telangana, India <br>CIN: L85195TG1984PLC004507<br>Tel:&nbsp;&nbsp;&nbsp;&nbsp; + 91 40 4900 2900<br>Fax:&nbsp;&nbsp;&nbsp;&nbsp; + 91 40 4900 2999<br>Email: <u>mail@drreddys.com</u><br>Web: <u>www.drreddys.com</u> |

---

July 24, 2025

National Stock Exchange of India Ltd. (Stock Code: DRREDDY)

BSE Limited (Stock Code: 500124)

New York Stock Exchange Inc. (Stock Code: RDY)

NSE IFSC Ltd. (Stock Code: DRREDDY)

Dear Sir/Madam,

**Sub.: <u>Outcome of 41<sup>st</sup> Annual General Meeting and Voting results</u>**

This is with reference to our earlier letters dated May 09, 2025 and June 30, 2025, regarding the 41<sup>st</sup> Annual General Meeting (AGM) of the Company, held today i.e. July 24, 2025.

In accordance with Regulation 44 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (SEBI Listing Regulations), this is to inform you that the Members of the Company transacted the business as stated in the Notice of 41<sup>st</sup> AGM, dated May 09, 2025, through Video Conferencing (VC) /Other Audio Visual Means (OAVM).

In this regard, please find enclosed the following:

&nbsp;&nbsp;&nbsp;&nbsp;1. Pursuant to Regulation 30 of the SEBI Listing Regulations, summary of the 41<sup>st</sup> AGM proceedings is enclosed as Annexure - A.

&nbsp;&nbsp;&nbsp;&nbsp;2. The consolidated Report of Scrutinizer on remote e-voting & e-voting during the AGM is enclosed as Annexure - B.

&nbsp;&nbsp;&nbsp;&nbsp;3. The agenda-wise disclosure of voting details is enclosed as Annexure - C.

The above are also being uploaded on the Company's website at www.drreddys.com and on the website of National Securities Depository Limited (NSDL) at www.evoting.nsdl.com.

For **Dr. Reddy's Laboratories Limited**

![](rdy0785_ex99-1img02.jpg)<br>

K Randhir Singh

***Company Secretary, Compliance Officer and Head-CSR***

Encl: As above

CC: National Securities Depositary Limited (NSDL)

**Dr. Reddy's Laboratories Ltd.**<br>8-2-337, Road No. 3, Banjara Hills<br>Hyderabad – 500 034, Telangana, India <br>CIN: L85195TG1984PLC004507<br>Tel:&nbsp;&nbsp;&nbsp;&nbsp; + 91 40 4900 2900<br>Fax:&nbsp;&nbsp;&nbsp;&nbsp; + 91 40 4900 2999<br>Email: <u>mail@drreddys.com</u><br>Web: <u>www.drreddys.com</u><br>

**DR. REDDY'S LABORATORIES LIMITED**

Summary of proceedings of the 41<sup>st</sup> Annual General Meeting (AGM) of the members of Dr. Reddy's Laboratories Limited ('the Company') held on Thursday, July 24, 2025 at 11.00 AM (IST) through Video Conferencing (VC) /Other Audio Visual Means (OAVM).

**Directors Present through VC:**

1. Mr. K Satish Reddy Chairman and Member, participated from Hyderabad, India

2. Mr. G V Prasad Co-Chairman and Managing Director and Member, participated from Hyderabad, India

3. Mr. Leo Puri Independent Director, Chairman of Stakeholders' Relationship Committee, participated from Singapore

4. Ms. Shikha Sharma Independent Director, Chairperson of Risk Management Committee, participated from Mumbai, India

5. Dr. K P Krishnan Independent Director, Chairman of the Sustainability & CSR Committee, participated from New Delhi, India

6. Ms. Penny Wan Independent Director, participated from Hyderabad, India

7. Mr. Arun M Kumar Independent Director, Chairman of the Audit Committee, participated from Bangalore, India

8. Dr. Claudio Albrecht Independent Director, Chairman of Science, Technology and Operations Committee, participated from Hyderabad, India

9. Ms. Alpna Seth Independent Director, participated from New Delhi, India

10. Mr. Sanjiv Mehta Independent Director, Chairman of Nomination, Governance and Remuneration Committee participated from Mumbai, India

**In attendance through VC, participated from Hyderabad, India:**

1. Mr. Erez Israeli Chief Executive Officer

2. Mr. M V Narasimham Chief Financial Officer

3. Mr. K Randhir Singh Company Secretary, Compliance Officer and Head-CSR

**Other representatives through VC:**

1. Representatives of M/s. S.R. Batliboi & Associates LLP, Statutory Auditors, participated from Hyderabad, India

2. Mr. Atul Mehta, Scrutinizer, Founding Partner, M/s. Mehta & Mehta, Practicing Company Secretaries, participated from Mumbai, India

3. Mr. Vaibhav Dandawate, Representatives of Makarand M. Joshi & Co., Company Secretaries, Secretarial Auditor, participated from Mumbai, India

**Members Present:**

Total 85 members holding 22,33,11,552 shares, attended the meeting through VC/OAVM.

Pursuant to Article 70 of the Articles of Association of the Company, Mr. K Satish Reddy, the Chairman of the Board took the chair and conducted the proceedings of the meeting. The requisite quorum being present, the meeting was called to order.

Thereafter, the Company Secretary informed the members that the meeting is being held through Video Conferencing/ Other Audio Visual Means (OAVM) in compliance with the applicable Circulars issued by the Ministry of Corporate Affairs (MCA) and Securities Exchange Board of India (SEBI). The Company Secretary further stated that since the Integrated Annual Report for FY2025 containing the Notice of the 41<sup>st</sup> AGM and the Auditor's Report was circulated to the members through electronic mode, the Notice convening the meeting and the Auditor's Report are taken as read. Thereafter, the Chairman delivered his speech followed with the address by the Co-Chairman and Managing Director.

The members were informed that the Integrated Annual Report for FY2025 containing the Audited Financial Statements (both Standalone and Consolidated) for the year ended March 31, 2025, Board's and Auditor's report had been sent through electronic mode to all the members whose e-mail addresses were registered with the Company/ Depository Participant(s)/ Registrar and Transfer Agent. The members were also informed that the original documents, as referred to in the Integrated Annual Report, along with the statutory registers were made available for inspection before the 41<sup>st</sup> AGM and were also available during the AGM for inspection in electronic mode.

Thereafter, the moderator opened the Question & Answer session for the Speaker Shareholders to ask their queries

Members attending the AGM, who had pre-registered themselves as speakers were given an opportunity to ask questions or comments. In addition to certain queries on financial statements, the members sought clarifications on key business and financial/operational matters. These queries were adequately responded to by the Management

The members were further informed that the Company had provided to the members facility to cast their votes electronically, on all resolutions set forth in the Notice of the 41<sup>st</sup> AGM through remote e-voting provided by NSDL. The remote e-voting facility was open from Sunday, July 20, 2025 (9.00 AM IST) to Wednesday, July 23, 2025 (5.00 PM IST). Members who attended the AGM and had not cast their votes through remote e-voting prior to the meeting were provided an opportunity to cast their votes during the AGM through the e-voting facility provided by NSDL.

The following items of business, as per the Notice of the 41<sup>st</sup> AGM dated May 09, 2025 were transacted at the meeting:

**Ordinary Business**

1. Adoption of Audited Financial Statements (Standalone and Consolidated) of the Company for the year ended March 31, 2025, together with the Reports of the Board of Directors and Auditors thereon (Ordinary Resolution).

2. Declaration of dividend of Rs. 8 per equity share for the FY2025 (Ordinary Resolution).

3. Re-appointment of Mr. G V Prasad (DIN: 00057433), as a Director, who retires by rotation, and being eligible offers himself for re-appointment (Ordinary Resolution).

**Special Business**

4. Approval of the re-appointment of Mr. G V Prasad (DIN: 00057433), as Whole-time Director designated as Co-Chairman and Managing Director (Ordinary Resolution).

5. Approval of the remuneration payable to Cost Auditors, M/s. Sagar & Associates, Cost Accountants, for the financial year ending March 31, 2026 (Ordinary Resolution).

6. Approval of appointment of M/s. Makarand M. Joshi & Co., Company Secretaries as Secretarial Auditor of the Company (Ordinary Resolution).

The Chairman informed the members that Mr. Atul Mehta (Membership No. F5782 and COP No. 2486), Founding Partner, M/s Mehta & Mehta, Company Secretaries, was appointed as the Scrutinizer for scrutinizing the processes of remote e-voting prior to the meeting and e-voting during the AGM in a fair and transparent manner and to report on the voting results for the items as per the Notice of the 41<sup>st</sup> AGM. The Chairman also informed the members that the Company Secretary is authorised on behalf of the board, to declare the results of the voting.

The meeting started at 11:00 a.m. and concluded at 12:38 p.m. (including 30 minutes time allowed for e-voting during AGM).

The Scrutinizer's Report was received, and accordingly all the resolutions as set out in the Notice of the 41<sup>st</sup> AGM were declared as passed by requisite majority.

For **Dr. Reddy's Laboratories Limited**

![](rdy0785_ex99-1img03.jpg)

K Randhir Singh

***Company Secretary, Compliance Officer and Head-CSR***

![](rdy0785_ex99-1img04.jpg)<br>

![](rdy0785_ex99-1img05.jpg)<br>

<br>![](rdy0785_ex99-1img06.jpg)<br>

![](rdy0785_ex99-1img07.jpg)<br>

![](rdy0785_ex99-1img08.jpg)<br>

![](rdy0785_ex99-1img09.jpg)<br>

![](rdy0785_ex99-1img10.jpg)<br>

![](rdy0785_ex99-1img11.jpg)<br>

![](rdy0785_ex99-1img12.jpg)<br>

![](rdy0785_ex99-1img13.jpg)<br>

![](rdy0785_ex99-1img14.jpg)<br>

![](rdy0785_ex99-1img15.jpg)<br>

![](rdy0785_ex99-1img20.jpg)<br>

![](rdy0785_ex99-1img21.jpg)<br>

![](rdy0785_ex99-1img22.jpg)<br>

![](rdy0785_ex99-1img23.jpg)<br>

![](rdy0785_ex99-1img16.jpg)<br>

![](rdy0785_ex99-1img17.jpg)<br>

![](rdy0785_ex99-1img18.jpg)<br>

![](rdy0785_ex99-1img19.jpg)<br>

<br>